Is CERE undervalued or overvalued?

As of 2025-03-25, the Intrinsic Value of Cerevel Therapeutics Holdings Inc (CERE) is -12.64 USD. This CERE valuation is based on the model Peter Lynch Fair Value. With the current market price of 44.96 USD, the upside of Cerevel Therapeutics Holdings Inc is -128.11%. This means that CERE is overvalued by 128.11%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-12.64 - -12.64	-12.64	-128.11%
P/E	(12.64) - (12.64)	(12.64)	-128.1%
DDM - Stable	(24.39) - (83.89)	(54.14)	-220.4%
DDM - Multi	(1.40) - (3.73)	(2.03)	-104.5%